Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial
Benoist Chibaudel*, Julie Henriques, Manel Rakez, Baruch Brenner, Tae Won Kim, Mercedes Martinez-Villacampa, Javier Gallego-Plazas, Andres Cervantes, Katharine Shim, Derek Jonker, Veronique Guerin-Meyer, Laurent Mineur, Chiara Banzi, Alice Dewdney, Thitiya Dejthevaporn, Haiko J. Bloemendal, Arnaud Roth, Markus Moehler, Enrique Aranda, Eric Van CutsemJosep Tabernero, Hans Joachim Schmoll, Paulo M. Hoff, Thierry André, Aimery De Gramont
Research output: Contribution to journal › Article › peer-review
10Scopus
citations
Fingerprint
Dive into the research topics of 'Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial'. Together they form a unique fingerprint.